Insulin binding to myotonic dystrophy fibroblasts

Insulin receptor binding was examined in cultured skin fibroblasts from 10 myotonic dystrophy patients and 10 age- and sex-matched control subjects. The conditions for insulin binding to fibroblasts were optimal and employed HEPES binding buffer, pH 8.0 at 15 °C for 5 h. These conditions correspond...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the neurological sciences 1983-02, Vol.58 (2), p.289-295
Hauptverfasser: Lam, Lister, Hudson, Arthur J, Strickland, Kenneth P, Tevaarwerk, Gerald J.M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 295
container_issue 2
container_start_page 289
container_title Journal of the neurological sciences
container_volume 58
creator Lam, Lister
Hudson, Arthur J
Strickland, Kenneth P
Tevaarwerk, Gerald J.M
description Insulin receptor binding was examined in cultured skin fibroblasts from 10 myotonic dystrophy patients and 10 age- and sex-matched control subjects. The conditions for insulin binding to fibroblasts were optimal and employed HEPES binding buffer, pH 8.0 at 15 °C for 5 h. These conditions correspond to those previously employed with monocytes from MyD subjects. The normalized initial insulin binding capacity showed a decrease of 62% from 5.04 ± 0.28% of the total labeled insulin added/mg protein in the control to 1.93 ± 0.13% in the myotonic dystrophy group ( P < 0.01) due mainly to a marked reduction in high affinity receptors or in receptor affinity. The addition of 1.0 ng/ml of unlabeled insulin produced significant decreases to 3.80 ± 0.25% in the control group and 1.24 ± 0.09% in the MyD group. The results are similar to previously reported findings with monocytes from myotonic dystrophy patients and suggest that a surface membrane defect exists in this disease. However, the conditions that have been employed in the binding procedures in all of the studies, while optimal, are performed at a high pH and low temperature and could have an important bearing on the interpretation of a membrane disorder.
doi_str_mv 10.1016/0022-510X(83)90223-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80421032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0022510X8390223X</els_id><sourcerecordid>80421032</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-74b05ba1f6f6ddab924c6cc7eaac466a2e50772fecf143b67fcbcde4796b6b253</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhveg1Fr9Bwo5iR6i-5FskosgxY9CwYtCb8t-zOpKkq27iZB_b2pDj56Gmfd9Z5gHoQuCbwkm_A5jStOc4M11yW6qsWHp5gjND-MTdBrjF8aYl2U1QzPOWMXLfI7Iqo197dpEuda49iPpfNIMvvOt04kZYhf89nNIrFPBq1rGLp6hYyvrCOdTXaD3p8e35Uu6fn1eLR_WqWZ50aVFpnCuJLHccmOkqmimudYFSKkzziWFHBcFtaAtyZjihdVKG8iKiiuuaM4W6Gq_dxv8dw-xE42LGupatuD7KEqcUYIZHY3Z3qiDjzGAFdvgGhkGQbDY0RE7DGKHQZRM_NERmzF2Oe3vVQPmEJrQjPr9XofxyR8HQUTtoNVgXADdCePd_wd-AbFUd3I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80421032</pqid></control><display><type>article</type><title>Insulin binding to myotonic dystrophy fibroblasts</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Lam, Lister ; Hudson, Arthur J ; Strickland, Kenneth P ; Tevaarwerk, Gerald J.M</creator><creatorcontrib>Lam, Lister ; Hudson, Arthur J ; Strickland, Kenneth P ; Tevaarwerk, Gerald J.M</creatorcontrib><description>Insulin receptor binding was examined in cultured skin fibroblasts from 10 myotonic dystrophy patients and 10 age- and sex-matched control subjects. The conditions for insulin binding to fibroblasts were optimal and employed HEPES binding buffer, pH 8.0 at 15 °C for 5 h. These conditions correspond to those previously employed with monocytes from MyD subjects. The normalized initial insulin binding capacity showed a decrease of 62% from 5.04 ± 0.28% of the total labeled insulin added/mg protein in the control to 1.93 ± 0.13% in the myotonic dystrophy group ( P &lt; 0.01) due mainly to a marked reduction in high affinity receptors or in receptor affinity. The addition of 1.0 ng/ml of unlabeled insulin produced significant decreases to 3.80 ± 0.25% in the control group and 1.24 ± 0.09% in the MyD group. The results are similar to previously reported findings with monocytes from myotonic dystrophy patients and suggest that a surface membrane defect exists in this disease. However, the conditions that have been employed in the binding procedures in all of the studies, while optimal, are performed at a high pH and low temperature and could have an important bearing on the interpretation of a membrane disorder.</description><identifier>ISSN: 0022-510X</identifier><identifier>DOI: 10.1016/0022-510X(83)90223-X</identifier><identifier>PMID: 6339685</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Aged ; Female ; Fibroblasts - metabolism ; Humans ; Insulin - metabolism ; Kinetics ; Male ; Middle Aged ; Muscular Dystrophies - metabolism ; Receptor, Insulin - metabolism</subject><ispartof>Journal of the neurological sciences, 1983-02, Vol.58 (2), p.289-295</ispartof><rights>1983</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-74b05ba1f6f6ddab924c6cc7eaac466a2e50772fecf143b67fcbcde4796b6b253</citedby><cites>FETCH-LOGICAL-c357t-74b05ba1f6f6ddab924c6cc7eaac466a2e50772fecf143b67fcbcde4796b6b253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0022-510X(83)90223-X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6339685$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lam, Lister</creatorcontrib><creatorcontrib>Hudson, Arthur J</creatorcontrib><creatorcontrib>Strickland, Kenneth P</creatorcontrib><creatorcontrib>Tevaarwerk, Gerald J.M</creatorcontrib><title>Insulin binding to myotonic dystrophy fibroblasts</title><title>Journal of the neurological sciences</title><addtitle>J Neurol Sci</addtitle><description>Insulin receptor binding was examined in cultured skin fibroblasts from 10 myotonic dystrophy patients and 10 age- and sex-matched control subjects. The conditions for insulin binding to fibroblasts were optimal and employed HEPES binding buffer, pH 8.0 at 15 °C for 5 h. These conditions correspond to those previously employed with monocytes from MyD subjects. The normalized initial insulin binding capacity showed a decrease of 62% from 5.04 ± 0.28% of the total labeled insulin added/mg protein in the control to 1.93 ± 0.13% in the myotonic dystrophy group ( P &lt; 0.01) due mainly to a marked reduction in high affinity receptors or in receptor affinity. The addition of 1.0 ng/ml of unlabeled insulin produced significant decreases to 3.80 ± 0.25% in the control group and 1.24 ± 0.09% in the MyD group. The results are similar to previously reported findings with monocytes from myotonic dystrophy patients and suggest that a surface membrane defect exists in this disease. However, the conditions that have been employed in the binding procedures in all of the studies, while optimal, are performed at a high pH and low temperature and could have an important bearing on the interpretation of a membrane disorder.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Female</subject><subject>Fibroblasts - metabolism</subject><subject>Humans</subject><subject>Insulin - metabolism</subject><subject>Kinetics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Muscular Dystrophies - metabolism</subject><subject>Receptor, Insulin - metabolism</subject><issn>0022-510X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhveg1Fr9Bwo5iR6i-5FskosgxY9CwYtCb8t-zOpKkq27iZB_b2pDj56Gmfd9Z5gHoQuCbwkm_A5jStOc4M11yW6qsWHp5gjND-MTdBrjF8aYl2U1QzPOWMXLfI7Iqo197dpEuda49iPpfNIMvvOt04kZYhf89nNIrFPBq1rGLp6hYyvrCOdTXaD3p8e35Uu6fn1eLR_WqWZ50aVFpnCuJLHccmOkqmimudYFSKkzziWFHBcFtaAtyZjihdVKG8iKiiuuaM4W6Gq_dxv8dw-xE42LGupatuD7KEqcUYIZHY3Z3qiDjzGAFdvgGhkGQbDY0RE7DGKHQZRM_NERmzF2Oe3vVQPmEJrQjPr9XofxyR8HQUTtoNVgXADdCePd_wd-AbFUd3I</recordid><startdate>198302</startdate><enddate>198302</enddate><creator>Lam, Lister</creator><creator>Hudson, Arthur J</creator><creator>Strickland, Kenneth P</creator><creator>Tevaarwerk, Gerald J.M</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198302</creationdate><title>Insulin binding to myotonic dystrophy fibroblasts</title><author>Lam, Lister ; Hudson, Arthur J ; Strickland, Kenneth P ; Tevaarwerk, Gerald J.M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-74b05ba1f6f6ddab924c6cc7eaac466a2e50772fecf143b67fcbcde4796b6b253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Female</topic><topic>Fibroblasts - metabolism</topic><topic>Humans</topic><topic>Insulin - metabolism</topic><topic>Kinetics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Muscular Dystrophies - metabolism</topic><topic>Receptor, Insulin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lam, Lister</creatorcontrib><creatorcontrib>Hudson, Arthur J</creatorcontrib><creatorcontrib>Strickland, Kenneth P</creatorcontrib><creatorcontrib>Tevaarwerk, Gerald J.M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lam, Lister</au><au>Hudson, Arthur J</au><au>Strickland, Kenneth P</au><au>Tevaarwerk, Gerald J.M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insulin binding to myotonic dystrophy fibroblasts</atitle><jtitle>Journal of the neurological sciences</jtitle><addtitle>J Neurol Sci</addtitle><date>1983-02</date><risdate>1983</risdate><volume>58</volume><issue>2</issue><spage>289</spage><epage>295</epage><pages>289-295</pages><issn>0022-510X</issn><abstract>Insulin receptor binding was examined in cultured skin fibroblasts from 10 myotonic dystrophy patients and 10 age- and sex-matched control subjects. The conditions for insulin binding to fibroblasts were optimal and employed HEPES binding buffer, pH 8.0 at 15 °C for 5 h. These conditions correspond to those previously employed with monocytes from MyD subjects. The normalized initial insulin binding capacity showed a decrease of 62% from 5.04 ± 0.28% of the total labeled insulin added/mg protein in the control to 1.93 ± 0.13% in the myotonic dystrophy group ( P &lt; 0.01) due mainly to a marked reduction in high affinity receptors or in receptor affinity. The addition of 1.0 ng/ml of unlabeled insulin produced significant decreases to 3.80 ± 0.25% in the control group and 1.24 ± 0.09% in the MyD group. The results are similar to previously reported findings with monocytes from myotonic dystrophy patients and suggest that a surface membrane defect exists in this disease. However, the conditions that have been employed in the binding procedures in all of the studies, while optimal, are performed at a high pH and low temperature and could have an important bearing on the interpretation of a membrane disorder.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>6339685</pmid><doi>10.1016/0022-510X(83)90223-X</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-510X
ispartof Journal of the neurological sciences, 1983-02, Vol.58 (2), p.289-295
issn 0022-510X
language eng
recordid cdi_proquest_miscellaneous_80421032
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adolescent
Adult
Aged
Female
Fibroblasts - metabolism
Humans
Insulin - metabolism
Kinetics
Male
Middle Aged
Muscular Dystrophies - metabolism
Receptor, Insulin - metabolism
title Insulin binding to myotonic dystrophy fibroblasts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T02%3A13%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insulin%20binding%20to%20myotonic%20dystrophy%20fibroblasts&rft.jtitle=Journal%20of%20the%20neurological%20sciences&rft.au=Lam,%20Lister&rft.date=1983-02&rft.volume=58&rft.issue=2&rft.spage=289&rft.epage=295&rft.pages=289-295&rft.issn=0022-510X&rft_id=info:doi/10.1016/0022-510X(83)90223-X&rft_dat=%3Cproquest_cross%3E80421032%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80421032&rft_id=info:pmid/6339685&rft_els_id=0022510X8390223X&rfr_iscdi=true